B cell deficiency in patients with relapsed and refractory acute myeloid leukemia
Clin Hematol Int
.
2020 Sep;2(3):125-128.
doi: 10.2991/chi.k.200712.001.
Epub 2020 Jul 29.
Authors
Meghali Goswami
1
2
,
Katherine E Lindblad
1
,
Rahul Ramraj
1
,
Pradeep K Dagur
3
,
Julie Thompson
1
,
J Philip McCoy
3
,
Christopher S Hourigan
1
Affiliations
1
Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
2
Institute for Biomedical Sciences, The George Washington University, Washington, DC.
3
Flow Cytometry Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
PMID:
32924005
PMCID:
PMC7485901
DOI:
10.2991/chi.k.200712.001
No abstract available
Grants and funding
ZIA HL006163/ImNIH/Intramural NIH HHS/United States